Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 2/20 | 0.35 |
| ▸ | TGM2 | P21980 | 1/20 | 0.30 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.30 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18333590 | 0.90 | TSHR (0.42) | TSHRTGM2ZDHHC20ZDHHC2 | |
| SCHEMBL18329139 | 0.86 | TSHR (0.44) | TSHRACACBTGM2ZDHHC20ZDHHC2 | |
| SCHEMBL28967291 | 0.86 | TSHR (0.44) | TSHRACACBTGM2ZDHHC20ZDHHC2 | |
| SCHEMBL20381429 | 0.84 | TAS1R3 (0.44) | TSHRACACBTGM2ZDHHC20ZDHHC2 | |
| SCHEMBL2559046 | 0.84 | TAS1R3 (0.44) | TSHRACACBTGM2ZDHHC20ZDHHC2 | |
| SCHEMBL28750633 | 0.83 | TSHR (0.52) | TSHRACACBTGM2ZDHHC20ZDHHC2 | |
| SCHEMBL36064 | 0.83 | TSHR (0.52) | TSHRACACBTGM2ZDHHC20ZDHHC2 | |
| Ammonia Solution, Strong SCHEMBL31228295 | 0.82 | TSHR (0.50) | TSHRACACBTGM2ZDHHC20ZDHHC2 | |
| SCHEMBL10638254 | 0.82 | TSHR (0.50) | TSHRACACBTGM2ZDHHC20ZDHHC2 | |
| SCHEMBL2722430 | 0.81 | ZDHHC20 (0.44) | TSHRTGM2ZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160369017-A1 | CURABLE COMPOSITION, POLYMER FUNCTIONAL CURED PRODUCT, WATER-SOLUBLE ACRYLAMIDE COMPOUND, AND METHOD FOR MANUFACTURING SAME | FUJIFILM CORPORATION (JP) | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160369017-A1 | CURABLE COMPOSITION, POLYMER FUNCTIONAL CURED PRODUCT, WATER-SOLUBLE ACRYLAMIDE COMPOUND, AND METHOD FOR MANUFACTURING SAME | MRPL21, WDR1, CCNT1 | TSHR 3075/4885ACACB 1998/4885TGM2 1510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.